| Stock | PriceCurrent trading price. | Market CapTotal market capitalization. | FKPrice to Earnings ratio. | PD/DDPrice to Book ratio. | EV/EBITDAEnterprise Value / EBITDA. | ROICReturn on Invested Capital. | WACCWeighted Average Cost of Capital (WACC). | PUSLAFinancial health score (0-100). | DamodaranValuation score. | Intrinsic ValueFair value via DCF model. | Potential %Expected upside potential %. | Dalio RiskDalio Debt Cycle Score | Debt/EquityDebt to Equity ratio. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
III
|
2,819.00 | 28.7B | 5.43 | 0.93 | — | — | — | 78 | 62 | 5,777.42 | +72.4% | 92 | 0.04 |
|
LSEG
|
8,502.00 | 41.2B | 32.96 | 1.86 | 10.77 | — | — | 46 | 25 | 7,055.48 | -12.3% | 81 | 0.53 |
|
EXPN
|
2,926.00 | 25.9B | 29.66 | 6.84 | 15.79 | — | — | 43 | 36 | 1,597.26 | -34.1% | 87 | 0.99 |
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.